. 2013 Dec 23;8(12):e83075. doi: 10.1371/journal.pone.0083075

Table 2. Pulmonary leukocytes in FI-RSV and G-A2 peptide vaccinated mice 5 days after RSV challenge^a.

Phenotype	FI-A2+ A2 (x10³)	FI-A2+G-A2 +A2 (x10³)
			% Reduction
CD3	146.1 + 20.2	63.7 + 16.3	56
B220	27.1+3.7	14.9 + 3.8	45
DX5	172.8+ 2.4	8.6 + 2.2	95
CD11b	55.9 + 7.7	26.7 + 6.8	52
RB6-8C5	31.1 + 4.3	21.1 + 5.4	32

^a Data represent the mean total BAL cells expressing CD3 (T cell marker), CD45R/B220 (B cell marker), DX5, (NK cell marker), CD11b (macrophage cell marker) or RB6-8C5 (PMN cell marker) from mice vaccinated with FI-A2 alone or with FI-A2 and G-A2 peptide, five days after RSV A2 challenge. The total number of BAL cells expressing a particular phenotype was determined by multiplying the mean total number of BAL cells by the mean percentage of cells expressing that phenotype. Boldface values indicate a significant decrease (p<0.05) in the number of BAL cells expressing a particular phenotype with addition of the G-A2 to FI-A2 vaccination.

Table 2. Pulmonary leukocytes in FI-RSV and G-A2 peptide vaccinated mice 5 days after RSV challenge a .

Table 2. Pulmonary leukocytes in FI-RSV and G-A2 peptide vaccinated mice 5 days after RSV challenge^a.